Coronavírus e o Coração | Um Relato de Caso sobre a Evolução da COVID-19 Associado à Evolução Cardiológica

Abstract

Rente Coronavirus and the HeartArq Bras Cardiol. 2020; 114(5):839-842

Comorbidades E Covid-19

“…Outra notável diferença é a capacidade de transmissão, onde uma pessoa infectada é capaz de transmitir a doença através de transmissão direta para em médias três outras pessoas por meio de tosse, espirro e perdigotos além de transmissão por contato com mucosa oral, nasal e dos olhos (TUÑAS, SILVA, SANTIAGO, MAIA, SILVA-JUNIOR, 2020) O SARS-CoV-2 origina uma doença chamada de COVID-19, que teve um rápido surto a partir de novembro de 2019, tendo um impacto grande em escala global. No dia 10 de março de 2020, cerca de quatro meses após o primeiro surto, o mundo já apresentava 113.702 pacientes confirmados em laboratório com a COVID-19 e 4.012 mortes (RENTE, UEZATO JUNIOR, UEZATO, 2020).…”

Coronavirus in pediatrics: report of two cases and review of the literature

“…The gold standard test for diagnosing COVID-19 is the RT-PCR sample. The oropharyngeal swab does not have the same accuracy (7) . In the first presented case, the RT-PCR test was used as a confirmation, as COVID-19 was not proposed as the first hypothesis.…”

Coronavirus in a patient with hepatitis C: case report

“…In the literature we did not find many cases involving patients with hepatitis, therefore, we cannot state whether such a condition would actually be a risk factor for a worst evolution of the disease. The RT-PCR sample has been proving a decisive laboratory tool for the establishment of a definite diagnosis (7) , being very useful in the current scenario of this pandemic.…”

Cardiovascular damage due to COVID-19: what do we need to know?

“…In the case report by Rente et al (2020) 15 , a diabetic patient with Covid-19 presented with a severe cardiovascular involvement secondary to the inflammatory process. Computed Tomography (CT) revealed thickening of the myocardial wall with a slight increase in the cardiac area.…”

Coronavirus Myocarditis: Case Report

“…[8][9][10] Of these disorders, myocarditis comprises approximately 7.2% of the cardiovascular complications related to the novel coronavirus. 11 In this phase of disease progression, transthoracic echocardiography should be the method of choice to diagnose and monitor patients, improving the therapeutic management for providing hemodynamic data since patients with ventricular dysfunction are more likely to need mechanical ventilation, which consequently results in a worse prognosis. 3,12 This report presents the case of a patient with myocardial involvement induced by COVID-19 and its clinical and echocardiographic progression during hospitalization.…”